Edwards Lifesciences Corp (EW)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 600M 1.2B 1.8B Q3 '21: 1.3B Q4 '21: 1.3B Q1 '22: 1.3B Q2 '22: 1.4B Q3 '22: 1.3B Q4 '22: 429.9M Q1 '23: 1.5B Q2 '23: 1.3B Q3 '23: 1.2B Q4 '23: 1.3B Q1 '24: 1.3B Q2 '24: 1.4B Q3 '24: 1.4B Q4 '24: 1.4B Q1 '25: 1.4B Q2 '25: 1.5B Q3 '25: 1.6B Q4 '25: 1.6B Q1 '26: 1.6B Q2 '26: 1.7B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

0 500M 1B 1.5B Q3 '21: 998.5M Q4 '21: 1B Q1 '22: 1B Q2 '22: 1.1B Q3 '22: 1.1B Q4 '22: 528.7M Q1 '23: 1.1B Q2 '23: 1B Q3 '23: 992.8M Q4 '23: 1B Q1 '24: 1B Q2 '24: 1.1B Q3 '24: 1.1B Q4 '24: 1.1B Q1 '25: 1.1B Q2 '25: 1.2B Q3 '25: 1.2B Q4 '25: 1.2B Q1 '26: 1.3B Q2 '26: 1.3B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income Quarterly

0 200M 400M 600M Q3 '21: 390.3M Q4 '21: 374.4M Q1 '22: 438.8M Q2 '22: 459.5M Q3 '22: 402.4M Q4 '22: 197.7M Q1 '23: 388.4M Q2 '23: 263.5M Q3 '23: 365.9M Q4 '23: 346.8M Q1 '24: 349M Q2 '24: 366.5M Q3 '24: 350.6M Q4 '24: 312.6M Q1 '25: 394.8M Q2 '25: 411.2M Q3 '25: 307.1M Q4 '25: 151.1M Q1 '26: 477.6M Q2 '26: 513.2M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

0 1.5B 3B 4.5B Q3 '21: 340.1M Q4 '21: 335.3M Q1 '22: 373.6M Q2 '22: 406.4M Q3 '22: 343.5M Q4 '22: 398.4M Q1 '23: 340.5M Q2 '23: 307.1M Q3 '23: 384.9M Q4 '23: 369.9M Q1 '24: 351.9M Q2 '24: 366.3M Q3 '24: 3.1B Q4 '24: 385.6M Q1 '25: 358M Q2 '25: 333.2M Q3 '25: 291.1M Q4 '25: 91.2M Q1 '26: 380.7M Q2 '26: 241.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 150M 300M 450M Q2 '21: 334.3M Q3 '21: 311.7M Q4 '21: 309.5M Q1 '22: 299.3M Q2 '22: 269.4M Q3 '22: 253.8M Q1 '23: 329.5M Q2 '23: 256.9M Q3 '23: 250.6M Q4 '23: 251M Q1 '24: 286.9M Q2 '24: 275.5M Q3 '24: 262.9M Q4 '24: 292.2M Q1 '25: 301.6M Q2 '25: 344.4M Q3 '25: 345.2M Q4 '25: 343M Q1 '26: 362.6M Q2 '26: 392.4M Q3 '21 Q2 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-250M 0 250M 500M 750M Q3 '21: 531.9M Q4 '21: 373.6M Q1 '22: 293.3M Q2 '22: 332.2M Q3 '22: 309.9M Q4 '22: 282.8M Q1 '23: 314.1M Q2 '23: 33.6M Q3 '23: 411.5M Q4 '23: 136.6M Q1 '24: -53.5M Q2 '24: 371.5M Q3 '24: 351.8M Q4 '24: -127.5M Q1 '25: 280.4M Q2 '25: 290.2M Q3 '25: 573.7M Q4 '25: 450.9M Q1 '26: 43.8M Q2 '26: 651.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-200M 0 200M 400M 600M Q3 '21: 471.2M Q4 '21: 283.8M Q1 '22: 220.6M Q2 '22: 289.1M Q3 '22: 250M Q4 '22: 213.9M Q1 '23: 252.6M Q2 '23: -14.3M Q3 '23: 356.2M Q4 '23: 48.3M Q1 '24: -118.8M Q2 '24: 286.1M Q3 '24: 299.9M Q4 '24: -177.3M Q1 '25: 224.4M Q2 '25: 240.9M Q3 '25: 516.2M Q4 '25: 353.5M Q1 '26: -21.1M Q2 '26: 585M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 250M 500M 750M Q1 '20: 635.1M Q2 '20: 620.3M Q3 '20: 631M Q1 '21: 631.3M Q2 '21: 629.9M Q3 '21: 631.7M Q1 '22: 629.4M Q2 '22: 626.7M Q3 '22: 624.5M Q1 '23: 610.9M Q2 '23: 610.3M Q3 '23: 609.5M Q1 '24: 604.1M Q2 '24: 604.3M Q3 '24: 598.1M Q1 '25: 587.8M Q2 '25: 587.9M Q3 '25: 585.7M Q1 '26: 580.7M Q2 '26: 577.6M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 2.50 5.00 7.50 Q3 '21: 2.35 Q4 '21: 2.39 Q1 '22: 2.44 Q2 '22: 2.31 Q3 '22: 2.32 Q4 '22: 2.44 Q1 '23: 2.41 Q2 '23: 2.26 Q3 '23: 2.34 Q4 '23: 2.30 Q1 '24: 2.32 Q2 '24: 2.43 Q3 '24: 6.93 Q4 '24: 6.97 Q1 '25: 7.00 Q2 '25: 6.95 Q3 '25: 2.32 Q4 '25: 1.83 Q1 '26: 1.88 Q2 '26: 1.74 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.